Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines

Chronic myeloid leukemia (CML) is a myeloproliferative haematological malignancy characterized by constitutive activation of BCR-ABL1 tyrosine kinase in the majority of patients. BCR-ABL1 expression activates signaling pathways involved in cell proliferation and survival. Current treatment options f...

Descripción completa

Detalles Bibliográficos
Autores principales: Bilajac, Esma, Mahmutović, Lejla, Glamočlija, Una, Osmanović, Amar, Hromić-Jahjefendić, Altijana, Tambuwala, Murtaza M., Suljagić, Mirza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863870/
https://www.ncbi.nlm.nih.gov/pubmed/36676983
http://dx.doi.org/10.3390/metabo13010058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863870/
https://www.ncbi.nlm.nih.gov/pubmed/36676983
http://dx.doi.org/10.3390/metabo13010058

Ejemplares similares